Anti-Cell Staining Patterns in Juvenile Idiopathic Arthritis-Associated Uveitis: A Peek Behind the Curtain
Journal of Clinical Medicine · 21.05.2026 · 15 (10) · 3977
DOI: 10.3390/jcm15103977 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.05.2026. Verfasst von Marijan Frkovic und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, University Hospital Centre Zagreb, 10000 Zagreb, Croatia. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union–Next Generation EU.
Abstract (Originalsprache)
Objectives
We aimed to assess and compare Anti-Cell (AC) staining patterns and semi-quantitative titre levels of related antibodies in patients with juvenile idiopathic arthritis (JIA) with and without associated uveitis (JIA-U) to identify distinctive immunological profiles and contribute to a deeper understanding of JIA-U aetiopathogenesis.
Methods
Data from JIA patients diagnosed between January 2020 and December 2025 in our centre were evaluated. The HEp-2 indirect immunofluorescence assay (HEp-2 IFA) was used to determine AC patterns and semiquantitative titres of associated antibodies.
Results
217 JIA patients were evaluated: 161 (74%) without uveitis and 56 (26%) with JIA-U. The AC-1 pattern was detected in 94 of 217 children (43%). It was markedly enriched among children with JIA-U, present in 39 of 56 (70%), compared with 55 of 161 (34%) in the non-uveitis group. High staining intensity (i.e., semiquantitative titre ++/+++) of AC-1 was also more commonly detected in JIA-U patients (39%) compared to children without uveitis (11.8%). The AC-4 pattern was detected in 30 of 217 JIA patients (14%), but more commonly in the non-uveitis (17.4%) compared to the JIA-U group (3.6%).
Conclusions
JIA-U is closely linked to AC-1 staining patterns and higher semiquantitative titres of associated antibodies. Our results provide additional insight into the pathogenesis of JIA-U and underscore the significance of the new Paediatric Rheumatology International Trials Organisation (PRINTO) JIA classification criteria. The potential clinical relevance of AC patterns in children with JIA and JIA-U requires further multicentre studies involving larger cohorts and extended follow-up periods.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
- School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
- Department of Laboratory Diagnostics, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
- Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.
- Department of Ophthalmology, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
ORCID-Profile: Marijan Frkovic, Sanda Huljev Frkovic, Marija Jelusic
Förderung
- European Union–Next Generation EU
Zitieren
APA
Frkovic, M., Sabljak, I., Sremec, N. T., Kifer, D., Kozmar, A., Peric, S., Kutija, M. B., Rukavina, I., Sestan, M., Kifer, N., Frkovic, S. H., & Jelusic, M. (2026). Anti-Cell Staining Patterns in Juvenile Idiopathic Arthritis-Associated Uveitis: A Peek Behind the Curtain. Journal of Clinical Medicine, 15(10), 3977. https://doi.org/10.3390/jcm15103977
Vancouver
Frkovic M, Sabljak I, Sremec NT, Kifer D, Kozmar A, Peric S, et al. Anti-Cell Staining Patterns in Juvenile Idiopathic Arthritis-Associated Uveitis: A Peek Behind the Curtain. Journal of Clinical Medicine. 2026;15(10):3977. doi:10.3390/jcm15103977
BibTeX
@article{Frkovic2026,
author = {Frkovic, Marijan and Sabljak, Ivana and Sremec, Nada Tomic and Kifer, Domagoj and Kozmar, Ana and Peric, Sanja and Kutija, Marija Barisic and Rukavina, Iva and Sestan, Mario and Kifer, Nastasia and Frkovic, Sanda Huljev and Jelusic, Marija},
title = {Anti-Cell Staining Patterns in Juvenile Idiopathic Arthritis-Associated Uveitis: A Peek Behind the Curtain},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {10},
pages = {3977},
doi = {10.3390/jcm15103977}
}
EUVIMED